Charles A. Reinhart's most recent trade in Pacira BioSciences Inc was a trade of 12,220 Common Stock done . Disclosure was reported to the exchange on June 12, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pacira BioSciences Inc | Charles A. Reinhart | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 12,220 | 51,867 (0%) | 0% | 0 | Common Stock | |
| Pacira BioSciences Inc | Charles A. Reinhart | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.89 per share. | 03 Jun 2024 | 2,979 | 39,647 (0%) | 0% | 30.9 | 92,021 | Common Stock |
| Pacira BioSciences Inc | Charles A. Reinhart | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Charles A. Reinhart | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 9,000 | 42,626 (0%) | 0% | 0 | Common Stock | |
| Pacira BioSciences Inc | Charles A. Reinhart | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 37.87 per share. | 06 Jun 2023 | 1,371 | 33,626 (0%) | 0% | 37.9 | 51,913 | Common Stock |
| Pacira BioSciences Inc | Charles A. Reinhart | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 38.99 per share. | 06 Jun 2023 | 1,236 | 34,997 (0%) | 0% | 39.0 | 48,193 | Common Stock |
| Pacira BioSciences Inc | Charles A. Reinhart | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 19,900 | 19,900 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Charles A. Reinhart | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 7,950 | 36,233 (0%) | 0% | 0 | Common Stock | |
| Pacira BioSciences Inc | Charles A. Reinhart | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 61.37 per share. | 06 Jun 2022 | 2,516 | 28,283 (0%) | 0% | 61.4 | 154,417 | Common Stock |
| Pacira BioSciences Inc | Charles A. Reinhart | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 61.04 per share. | 04 Jun 2021 | 2,648 | 24,799 (0%) | 0% | 61.0 | 161,626 | Common Stock |